Industry: Chemical & Material
Published Date: 2024-01-12
Pages: 104 Pages
Report ld: 2203132
Request Sample
Customized Report
Iloperidone is an atypical antipsychotic, a combined dopamine (D2) and serotonin (5HT2) receptor antagonist. Iloperidone targets a selective set of dopamine, serotonin and also norepinephrine receptor subtypes.
The global Iloperidone API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Iloperidone API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Iloperidone API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Iloperidone API include Tecoland, Pharmaffiliates, Clearsynth, Jigs chemical, CBC, Struchem, Hangzhou Keying Chem, Jiaxing Carry Chemical and Conscientia Industrial, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Iloperidone API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iloperidone API.
MARKET SEGMENTATION
REPORT SCOPE
The Iloperidone API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Iloperidone API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iloperidone API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iloperidone API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Iloperidone API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Iloperidone API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Iloperidone API Market Overview
1.1 Product Definition
1.2 Iloperidone API Segment by Type
1.2.1 Global Iloperidone API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Iloperidone API Segment by Application
1.3.1 Global Iloperidone API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Research
1.3.3 Pharmaceutical
1.4 Global Market Growth Prospects
1.4.1 Global Iloperidone API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Iloperidone API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Iloperidone API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Iloperidone API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Iloperidone API Production Market Share by Manufacturers (2019-2024)
2.2 Global Iloperidone API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Iloperidone API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Iloperidone API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Iloperidone API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Iloperidone API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Iloperidone API, Product Offered and Application
2.8 Global Key Manufacturers of Iloperidone API, Date of Enter into This Industry
2.9 Iloperidone API Market Competitive Situation and Trends
2.9.1 Iloperidone API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Iloperidone API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Iloperidone API Production by Region
3.1 Global Iloperidone API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Iloperidone API Production Value by Region (2019-2030)
3.2.1 Global Iloperidone API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Iloperidone API by Region (2025-2030)
3.3 Global Iloperidone API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Iloperidone API Production by Region (2019-2030)
3.4.1 Global Iloperidone API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Iloperidone API by Region (2025-2030)
3.5 Global Iloperidone API Market Price Analysis by Region (2019-2024)
3.6 Global Iloperidone API Production and Value, Year-over-Year Growth
3.6.1 North America Iloperidone API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Iloperidone API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Iloperidone API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Iloperidone API Production Value Estimates and Forecasts (2019-2030)
3.6.5 India Iloperidone API Production Value Estimates and Forecasts (2019-2030)
4 Iloperidone API Consumption by Region
4.1 Global Iloperidone API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Iloperidone API Consumption by Region (2019-2030)
4.2.1 Global Iloperidone API Consumption by Region (2019-2024)
4.2.2 Global Iloperidone API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Iloperidone API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Iloperidone API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Iloperidone API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Iloperidone API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Iloperidone API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Iloperidone API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Iloperidone API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Iloperidone API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Iloperidone API Production by Type (2019-2030)
5.1.1 Global Iloperidone API Production by Type (2019-2024)
5.1.2 Global Iloperidone API Production by Type (2025-2030)
5.1.3 Global Iloperidone API Production Market Share by Type (2019-2030)
5.2 Global Iloperidone API Production Value by Type (2019-2030)
5.2.1 Global Iloperidone API Production Value by Type (2019-2024)
5.2.2 Global Iloperidone API Production Value by Type (2025-2030)
5.2.3 Global Iloperidone API Production Value Market Share by Type (2019-2030)
5.3 Global Iloperidone API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Iloperidone API Production by Application (2019-2030)
6.1.1 Global Iloperidone API Production by Application (2019-2024)
6.1.2 Global Iloperidone API Production by Application (2025-2030)
6.1.3 Global Iloperidone API Production Market Share by Application (2019-2030)
6.2 Global Iloperidone API Production Value by Application (2019-2030)
6.2.1 Global Iloperidone API Production Value by Application (2019-2024)
6.2.2 Global Iloperidone API Production Value by Application (2025-2030)
6.2.3 Global Iloperidone API Production Value Market Share by Application (2019-2030)
6.3 Global Iloperidone API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Tecoland
7.1.1 Tecoland Iloperidone API Corporation Information
7.1.2 Tecoland Iloperidone API Product Portfolio
7.1.3 Tecoland Iloperidone API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Tecoland Main Business and Markets Served
7.1.5 Tecoland Recent Developments/Updates
7.2 Pharmaffiliates
7.2.1 Pharmaffiliates Iloperidone API Corporation Information
7.2.2 Pharmaffiliates Iloperidone API Product Portfolio
7.2.3 Pharmaffiliates Iloperidone API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Pharmaffiliates Main Business and Markets Served
7.2.5 Pharmaffiliates Recent Developments/Updates
7.3 Clearsynth
7.3.1 Clearsynth Iloperidone API Corporation Information
7.3.2 Clearsynth Iloperidone API Product Portfolio
7.3.3 Clearsynth Iloperidone API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Clearsynth Main Business and Markets Served
7.3.5 Clearsynth Recent Developments/Updates
7.4 Jigs chemical
7.4.1 Jigs chemical Iloperidone API Corporation Information
7.4.2 Jigs chemical Iloperidone API Product Portfolio
7.4.3 Jigs chemical Iloperidone API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Jigs chemical Main Business and Markets Served
7.4.5 Jigs chemical Recent Developments/Updates
7.5 CBC
7.5.1 CBC Iloperidone API Corporation Information
7.5.2 CBC Iloperidone API Product Portfolio
7.5.3 CBC Iloperidone API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 CBC Main Business and Markets Served
7.5.5 CBC Recent Developments/Updates
7.6 Struchem
7.6.1 Struchem Iloperidone API Corporation Information
7.6.2 Struchem Iloperidone API Product Portfolio
7.6.3 Struchem Iloperidone API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Struchem Main Business and Markets Served
7.6.5 Struchem Recent Developments/Updates
7.7 Hangzhou Keying Chem
7.7.1 Hangzhou Keying Chem Iloperidone API Corporation Information
7.7.2 Hangzhou Keying Chem Iloperidone API Product Portfolio
7.7.3 Hangzhou Keying Chem Iloperidone API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Hangzhou Keying Chem Main Business and Markets Served
7.7.5 Hangzhou Keying Chem Recent Developments/Updates
7.8 Jiaxing Carry Chemical
7.8.1 Jiaxing Carry Chemical Iloperidone API Corporation Information
7.8.2 Jiaxing Carry Chemical Iloperidone API Product Portfolio
7.8.3 Jiaxing Carry Chemical Iloperidone API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Jiaxing Carry Chemical Main Business and Markets Served
7.7.5 Jiaxing Carry Chemical Recent Developments/Updates
7.9 Conscientia Industrial
7.9.1 Conscientia Industrial Iloperidone API Corporation Information
7.9.2 Conscientia Industrial Iloperidone API Product Portfolio
7.9.3 Conscientia Industrial Iloperidone API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Conscientia Industrial Main Business and Markets Served
7.9.5 Conscientia Industrial Recent Developments/Updates
7.10 Vesino Industrial
7.10.1 Vesino Industrial Iloperidone API Corporation Information
7.10.2 Vesino Industrial Iloperidone API Product Portfolio
7.10.3 Vesino Industrial Iloperidone API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Vesino Industrial Main Business and Markets Served
7.10.5 Vesino Industrial Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Iloperidone API Industry Chain Analysis
8.2 Iloperidone API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Iloperidone API Production Mode & Process
8.4 Iloperidone API Sales and Marketing
8.4.1 Iloperidone API Sales Channels
8.4.2 Iloperidone API Distributors
8.5 Iloperidone API Customers
9 Iloperidone API Market Dynamics
9.1 Iloperidone API Industry Trends
9.2 Iloperidone API Market Drivers
9.3 Iloperidone API Market Challenges
9.4 Iloperidone API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Iloperidone API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 127
USD 3950.00
(Single User License)
The global Iloperidone API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 131
USD 2900.00
(Single User License)
The global Iloperidone API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 145
USD 4900.00
(Single User License)
The global market for Iloperidone API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 104
USD 3950.00
(Single User License)
The global market for Iloperidone API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 87
USD 2900.00
(Single User License)
The global Iloperidone API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 79
USD 4250.00
(Single User License)
Iloperidone is an atypical antipsychotic, a combined dopamine (D2) and serotonin (5HT2) receptor antagonist. Iloperidone targets a selective set of dopamine, serotonin and also norepinephrine receptor subtypes.
Published Date: 2024-04-07
Pages: 106
USD 4900.00
(Single User License)
Iloperidone is an atypical antipsychotic, a combined dopamine (D2) and serotonin (5HT2) receptor antagonist. Iloperidone targets a selective set of dopamine, serotonin and also norepinephrine receptor subtypes.
Published Date: 2024-02-19
Pages: 126
USD 3950.00
(Single User License)
The global market for Iloperidone API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 127
The global Iloperidone API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 131
The global Iloperidone API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 145
The global market for Iloperidone API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 104
The global market for Iloperidone API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 87
The global Iloperidone API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 79
Iloperidone is an atypical antipsychotic, a combined dopamine (D2) and serotonin (5HT2) receptor antagonist. Iloperidone targets a selective set of dopamine, serotonin and also norepinephrine receptor subtypes.
Published: 2024-04-07
Pages: 106
Iloperidone is an atypical antipsychotic, a combined dopamine (D2) and serotonin (5HT2) receptor antagonist. Iloperidone targets a selective set of dopamine, serotonin and also norepinephrine receptor subtypes.
Published: 2024-02-19
Pages: 126
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now